We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

152 hedge funds and large institutions have $2.24B invested in Heron Therapeutics in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 19

79% more capital invested

Capital invested by funds: $1.25B → $2.24B (+$991M)

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

38% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 39

23% more funds holding

Funds holding: 124 → 152 (+28)

18.42% more ownership

Funds ownership: 107.15% → 125.57% (+18%)

10% more call options, than puts

Call options by funds: $39.4M | Put options by funds: $35.7M

Holders
152
Holders Change
+28
Holders Change %
+22.58%
% of All Funds
3.48%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.18%
New
47
Increased
54
Reduced
39
Closed
19
Calls
$39.4M
Puts
$35.7M
Net Calls
+$3.62M
Net Calls Change
-$7.32M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$49.3M
2
BBA
Baker Bros. Advisors
New York
+$44.6M
3
EAM
Eagle Asset Management
Florida
+$41.1M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$34.7M
5
BM
Bridger Management
New York
+$29M

Top Sellers

1
CC
Carlson Capital
Texas
-$26.2M
2
Franklin Resources
Franklin Resources
California
-$26.2M
3
RCMNY
Rubric Capital Management (New York)
New York
-$15.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$15M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
WEC
151
Winslow Evans & Crocker
Massachusetts
$28 – – –
Millennium Management
152
Millennium Management
New York
– -$5.71M -315,173 Closed
DAM
153
Deltec Asset Management
New York
– -$2.12M -117,000 Closed
SCA
154
Secor Capital Advisors
New York
– -$1.63M -90,099 Closed
ACM
155
Atika Capital Management
New York
– -$1.63M -90,000 Closed
Tudor Investment Corp
156
Tudor Investment Corp
Connecticut
– -$1.48M -81,951 Closed
Renaissance Technologies
157
Renaissance Technologies
New York
– -$1.44M -79,800 Closed
JGC
158
J. Goldman & Co
New York
– -$1.18M -65,263 Closed
TI
159
Trexquant Investment
Connecticut
– -$940K -51,907 Closed
ARTA
160
A.R.T. Advisors
New York
– -$910K -50,300 Closed
FRM
161
Fox Run Management
Connecticut
– -$399K -22,050 Closed
CAN
162
Claraphi Advisory Network
United States
– -$335K -18,500 Closed
CSS
163
Cubist Systematic Strategies
Connecticut
– -$315K -17,395 Closed
OPPM
164
Opus Point Partners Management
New York
– -$287K -15,874 Closed
PP
165
Paloma Partners
Connecticut
– -$231K -12,769 Closed
JG
166
Jefferies Group
New York
– -$214K -11,800 Closed
Parallax Volatility Advisers
167
Parallax Volatility Advisers
California
– -$125K -6,888 Closed
CA
168
Centerpoint Advisors
Massachusetts
– -$54K -3,000 Closed
Pacer Advisors
169
Pacer Advisors
Pennsylvania
– -$29K -1,600 Closed
KF
170
Krilogy Financial
Missouri
– -$4K -200 Closed
DWM
171
Destination Wealth Management
California
– +$45 +2 New
3 4 5 6
7

HRTX Hedge Fund Activity: Q1 2018 in Review

152 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2018, worth a combined $2.24B — up 79% from $1.25B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new HRTX positions and 19 closed out — a net gain of 28 holders — while 54 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $49.3M. The largest seller was Carlson Capital, cutting an estimated $26.2M.

  • 152 institutional investors held Heron Therapeutics (HRTX) as of Q1 2018, up from 124 in Q4 2017.
  • Funds reported $2.24B of Heron Therapeutics stock for Q1 2018, up 79% quarter-over-quarter.
  • 47 funds opened new Heron Therapeutics positions in Q1 2018 and 19 closed out, a net change of +28 holders.
  • The largest Heron Therapeutics buyer in Q1 2018 was Wellington Management Group, an estimated $49.3M added.
  • The largest Heron Therapeutics seller in Q1 2018 was Carlson Capital, an estimated $26.2M sold.

Based on aggregated 13F filings for Q1 2018.